Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

["Subclinical" thyroid disease].

Rolf Jorde1

  • 1Medisinsk avdeling Universitetssykehuset Nord-Norge 9038 Tromsø. rolf.jorde@rito.no

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|June 27, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Associations of per- and polyfluoroalkyl substances (PFAS) with key metabolic cardiovascular disease risk factors. The tromsø study.

Environmental research·2026
Same author

Why did we end up having so few vitamin D answers and what can we do about it? A provocative and narrative review.

The Journal of steroid biochemistry and molecular biology·2025
Same author

[Vitamin D can prevent diabetes].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2025
Same author

Exploring Interaction between Genetically Predicted Body Mass Index and Serum 25-Hydroxyvitamin D Levels on the Odds for Psoriasis in UK Biobank and the HUNT Study: A Factorial Mendelian Randomization Study.

JID innovations : skin science from molecules to population health·2025
Same author

The association between serum 25-hydroxyvitamin D levels and psoriasis in a large population-based cohort: a cross-sectional analysis of The Tromsø Study 2015-16.

The British journal of dermatology·2023
Same author

Vitamin D Status During Adolescence and the Impact of Lifestyle Changes: 2 Years' Follow-up From the Fit Futures Study.

The Journal of clinical endocrinology and metabolism·2023
Same journal

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

Correction: Management of acute epistaxis.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

A woman in her 70s with chest pain and elevated troponin T levels.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

More systematic follow-up after childbirth.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
See all related articles

Subclinical thyroid disease, often progressive, requires timely treatment. Patients with subclinical hypothyroidism may improve with thyroxine, while subclinical hyperthyroidism increases risks like atrial fibrillation.

Area of Science:

  • Endocrinology
  • Internal Medicine

Context:

  • Subclinical thyroid disease diagnosis and treatment present challenges.
  • Uncertainty exists regarding the necessity of treating subclinical thyroid conditions.

Purpose:

  • To review clinical symptoms and complications of subclinical thyroid disease.
  • To inform treatment decisions for subclinical thyroid dysfunction.

Summary:

  • Subclinical hypothyroidism (elevated TSH, normal free T4) may benefit from thyroxine, improving well-being, lipids, and blood pressure.
  • Subclinical hyperthyroidism (suppressed TSH, normal free T4) is linked to increased risks of atrial fibrillation and dementia.

Impact:

  • Highlights the progressive nature of subclinical thyroid disease.

Related Experiment Videos

  • Emphasizes the importance of prompt treatment once transient causes are excluded.
  • Provides evidence for thyroxine treatment in subclinical hypothyroidism.
  • Identifies risks associated with untreated subclinical hyperthyroidism.